Fox 26 Reporter Ivory Hecker Says She Was Told to ‘Cease and Desist’ Reporting on Hydroxychloroquine

Fox 26 reporter Ivory Hecker told Project Veritas founder James O’Keefe that the Fox affiliate moved to muzzle her reporting on Hydroxychloroquine because it went against “the corporate narrative,” which has allegedly been influenced by Fox’s advertisers, the Centers for Disease Control and Prevention (CDC), and vaccine companies.

Read More

Peter Navarro: ‘St. Fauci’ and Others Have Blood on Hands after Blocking Trump Admin. from Distributing 60 Million HCQ Tablets

Hydroxychloroquine tablets

It turns out that the anti-malaria drug former president Trump famously touted in March of 2020 as a promising treatment for COVID-19, would indeed have been a “game changer” if only it had been widely used.

Use of Hydroxychloroquine to treat the coronavirus can increase survival rates by over 100 percent, according to a new study.

Read More

Commentary: The Lethal Wages of Trump Derangement Madness

Trump protest

Think about it: For about five years, anything candidate, president-elect, and President Trump said or did, the media, the Left, and progressive popular culture opposed in Pavlovian fashion.

Anything that Trump touched was ridiculed or discredited—regardless of evidence, data, or cogency. The merits of a Trump policy, a Trump assessment, a Trump initiative were irrelevant—given the primordial hatred of the Left of all things Trump: the president, the person, the family. 

Under the reductionist malady of Trump Derangement Syndrome, facts and logic did not matter. Instead, anything not said or done in opposition to Trump empowered the supposed existential Trump threat. Ironically, some of the most deductive and reductionist Trump haters were supposedly professionals, the highly educated, and the self-proclaimed devotees of the Enlightenment. And yet in their uncontrolled aversion and detestation, they suspended all the rules of empiricism, logic, and rationality—and people died as a result.

Read More

Oversight Board Reverses Facebook Removal of Post Touting Hydroxychloroquine in COVID-19 Treatment

Facebook’s independent Oversight Board has reversed the social media platform’s decision to remove an October 2020 post pertaining to the drug hydroxychloroquine in the treatment of COVID-19.

“In October 2020, a user posted a video and accompanying text in French in a public Facebook group related to COVID-19,” the board explained on its website. “The post alleged a scandal at the Agence Nationale de Sécurité du Médicament (the French agency responsible for regulating health products), which refused to authorize hydroxychloroquine combined with azithromycin for use against COVID-19, but authorized and promoted remdesivir. The user criticized the lack of a health strategy in France and stated that “[Didier] Raoult’s cure” is being used elsewhere to save lives. The user’s post also questioned what society had to lose by allowing doctors to prescribe in an emergency a “harmless drug” when the first symptoms of COVID-19 appear.”

Read More

Dr. Simone Gold of America’s Frontline Doctors Responds to Twitter’s Censorship of Her Account

Dr. Simone Gold, a board-certified emergency physician and the founder of America’s Frontline Doctors, has responded to Twitter’s removal of her tweet about treatments for COVID-19 and locking her out of her account.

In her response, Dr. Gold – who also graduated from Stanford Law School after completing her medical degree – called out her temporary Twitter ban, calling the action “another classic case of tech censorship against anyone who speaks out against the media narrative.”

Read More

STUDY: Anti-Malarial Drug Used to Treat Lupus Helped COVID-19 Patients Survive, Despite Media Claims

An anti-malarial drug that President Donald Trump hyped as a potential therapy for the coronavirus helped some patients survive the disease while in the hospital, according to research published Wednesday.

Some of those who received hydroxychloroquine before acute symptoms began were much less likely to die from the virus, according to researchers at Henry Ford Health System in Michigan. Their findings come after other studies determined that the experimental drug provided little or no benefit to people struggling with the coronavirus, or COVID-19.

Read More

FDA Revokes Emergency Use of Malaria Drugs to Treat Coronavirus, Cites ‘Potential Risks’

U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause deadly side effects.

The Food and Drug Administration said the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the FDA said the drugs’ unproven benefits “do not outweigh the known and potential risks.”

Read More

Leading Study on Malaria Drug for Coronavirus Retracted: ‘Based on This Development, We Can No Longer Vouch for the Veracity of the Primary Data Source’

Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists.

Thursday’s retraction in the journal Lancet involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown.

Read More

Money and Politics Behind Anti-Hydroxychloroquine Bias, New Report Suggests

Remdesivir, an antiviral medication that was developed by the biopharmaceutical company Gilead Sciences, has been widely touted as the most promising drug to treat COVID-19, even though – so far – the new and expensive drug does not seem to be terribly effective at fighting the disease.

The anti-malaria drug hydroxychloroquine, on the other hand, is cheap, has been used safely for decades, and has shown great promise as a weapon in the fight against the coronavirus – yet after President Trump mentioned it as a promising potential treatment for the disease, the media immediately blasted him for touting an “unproven” and potentially unsafe drug.

Read More

President Trump: ‘I Happen to be Taking’ Hydroxychloroquine

President Donald Trump casually let slip Monday afternoon that he’s been taking hydroxychloroquine, the anti-malarial drug he’s touted as a promising treatment for Covid-19 patients that has become a lightning rod for controversy.

“A couple of weeks ago, I started taking it,” Trump told reporters during a roundtable at the White House with restaurant executives and industry leaders.

“I was just waiting to see your eyes light up when I said this,” Trump added.

Read More